These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12749505)

  • 1. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study.
    Quinn J; Ruoff GE; Ziter PS
    Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
    Norrby SR; Quinn J; Rangaraju M; Leroy B
    Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of short-course therapy with the ketolide telithromycin compared with 10 days of penicillin V for the treatment of pharyngitis/tonsillitis.
    Norrby SR; Rabie WJ; Bacart P; Mueller O; Leroy B; Rangaraju M; Butticaz-Iroudayassamy E
    Scand J Infect Dis; 2001; 33(12):883-90. PubMed ID: 11868759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
    Mathers Dunbar L; Hassman J; Tellier G
    Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients.
    Takker U; Dzyublyk O; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):421-9. PubMed ID: 13678479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
    Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
    Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days.
    Tellier G; Chang JR; Asche CV; Lavin B; Stewart J; Sullivan SD
    Curr Med Res Opin; 2004 May; 20(5):739-47. PubMed ID: 15140341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
    Niederman MS; Chang JR; Stewart J; Nusrat R; Nieman RB
    Curr Med Res Opin; 2004 May; 20(5):749-56. PubMed ID: 15140342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-Label, parallel-group, multicenter, randomized study of cefprozil versus erythromycin in children with group A streptococcal pharyngitis/tonsillitis.
    Brook I; Aronovitz GH; Pichichero ME
    Clin Ther; 2001 Nov; 23(11):1889-900. PubMed ID: 11768840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relief of symptoms in patients with group A beta-hemolytic streptococcus tonsillopharyngitis: comparison between telithromycin and penicillin V.
    Norrby SR; Chang J; Stewart JA; Brumpt I; Conway DP
    Scand J Infect Dis; 2003; 35(4):223-5. PubMed ID: 12839147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study.
    Jorgensen DM
    Clin Microbiol Infect; 2009 Dec; 15(12):1103-10. PubMed ID: 19929975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolides in the management of streptococcal pharyngitis/tonsillitis.
    Tarlow MJ
    Pediatr Infect Dis J; 1997 Apr; 16(4):444-8. PubMed ID: 9109157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.
    Niederman MS; Chang JR; Stewart J; Asche CV; Lavin B; Nusrat R; Sullivan SD
    Curr Med Res Opin; 2004 Jul; 20(7):969-80. PubMed ID: 15265241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia.
    Hagberg L; Torres A; van Rensburg D; Leroy B; Rangaraju M; Ruuth E
    Infection; 2002 Dec; 30(6):378-86. PubMed ID: 12478329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study.
    Portier H; Filipecki J; Weber P; Goldfarb G; Lethuaire D; Chauvin JP
    J Antimicrob Chemother; 2002 Feb; 49(2):337-44. PubMed ID: 11815577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telithromycin.
    Balfour JA; Figgitt DP
    Drugs; 2001; 61(6):815-29; discussion 830-1. PubMed ID: 11398913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis.
    Ferguson BJ; Guzzetta RV; Spector SL; Hadley JA
    Otolaryngol Head Neck Surg; 2004 Sep; 131(3):207-14. PubMed ID: 15365537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
    Syrogiannopoulos GA; Bozdogan B; Grivea IN; Ednie LM; Kritikou DI; Katopodis GD; Beratis NG; Applebaum PC;
    Pediatr Infect Dis J; 2004 Sep; 23(9):857-65. PubMed ID: 15361727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.